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ABSTRACT: The multicomponent protein toluene/o-xylene
monooxygenase (ToMO) activates molecular oxygen to
oxidize aromatic hydrocarbons. Prior to dioxygen activation,
two electrons are injected into each of two diiron(III) units of
the hydroxylase, a process that involves three redox active
proteins: the ToMO hydroxylase (ToMOH), Rieske protein
(ToMOC), and an NADH oxidoreductase (ToMOF). In
addition to these three proteins, a small regulatory protein is
essential for catalysis (ToMOD). Through steady state and
pre-steady state kinetics studies, we show that ToMOD
attenuates electron transfer from ToMOC to ToMOH in a
concentration-dependent manner. At substoichiometric con-
centrations, ToMOD increases the rate of turnover, which we
interpret to be a consequence of opening a pathway for oxygen transport to the catalytic diiron center in ToMOH. Excess
ToMOD inhibits steady state catalysis in a manner that depends on ToMOC concentration. Through rapid kinetic assays, we
demonstrate that ToMOD attenuates formation of the ToMOC−ToMOH complex. These data, coupled with protein docking
studies, support a competitive model in which ToMOD and ToMOC compete for the same binding site on the hydroxylase.
These results are discussed in the context of other studies of additional proteins in the superfamily of bacterial multicomponent
monooxygenases.
Bacterial multicomponent monooxygenases (BMMs) com-prise a family of enzymes that can hydroxylate or epoxidize
a variety of hydrocarbon substrates.1 Enzyme systems in this
superfamily contain either three or four component proteins
that are necessary for catalysis. Included are (i) a catalytic
hydroxylase housing two carboxylate-rich diiron active sites; (ii)
a 12−16 kDa regulatory protein; (iii) an NADH oxidoreductase
containing an NADH binding site, a ﬂavin adenine dinucleo-
tide, and a [2Fe-2S] ferredoxin cluster; and (iv) a Rieske
protein that is present only in the four-component BMMs.2
Protein interactions involving three-component BMMs have
been thoroughly discussed in the literature.3−5 Four-compo-
nent BMMs are less well investigated and more complicated,
because of their more extended electron transfer (ET) chain. In
three-component BMMs, the NADH oxidoreductase directly
reduces the diiron(III) centers in the hydroxylase, each by two
electrons, without the need for additional proteins.6−8 In
contrast, the NADH oxidoreductase of four-component BMMs
is incapable of directly reducing the hydroxylase.9 Instead, this
reduction is eﬀected by the Rieske protein, designated ToMOC
for the four-component BMM toluene/o-xylene monooxyge-
nase (ToMO). Thus, either a ternary complex, involving the
hydroxylase (ToMOH), ToMOC, and the NADH-oxidore-
ductase (ToMOF) proteins, must form, or sequential
interactions between ToMOC and ToMOH may occur, as
diagrammatically represented for the four-component BMM,
ToMO, in Scheme 1. Scheme 1 intentionally omits any
contribution from the regulatory protein, ToMOD.
Interactions of the regulatory protein with the hydroxylase
have been thoroughly described for the four-component BMM
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Scheme 1. Model for the Intermolecular Single-ET Events
within the Four-Component BMM, Toluene/o-Xylene
Monooxygenase (ToMO)
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toluene 4-monooxygenase (T4MO) using both equilibrium
binding measurements10 and X-ray crystallography.11,12 Re-
ported functions of the regulatory protein include opening
oxygen access to the diiron active site of the hydroxylase13,14
and closing the entry point for an aromatic substrate within the
hydroxylase.11 The roles of the regulatory protein with respect
to ET kinetics and the function of the ET proteins remain
unexplored for four-component BMMs, however.a To address
this issue, we carried out steady state and pre-steady state
experiments with the four-component BMM ToMO from
Pseudomonas sp. OX1. We ﬁnd that excess ToMOD inhibits
steady state turnover and that this inhibition is dependent on
the concentration of ToMOC and the temperature of the
reaction. ET studies demonstrate that the interaction between
reduced ToMOC (ToMOCred) and oxidized ToMOH
(ToMOHox) is diminished in the presence of ToMOD. Finally,
chemical cross-linking and protein docking studies support a
competitive binding model, in which ToMOC and ToMOD
compete for binding to the same region of ToMOH. These
conclusions provide evidence for a dynamic interaction of
ToMOH with both ToMOD and ToMOC. Possible functions
for these interactions are discussed in the context of previous
reports on three- and four-component BMMs.
■ EXPERIMENTAL PROCEDURES
General Methods. Plasmids for the component proteins of
ToMO were generously provided by the Di Donato laboratory
(Naples, Italy). Expression and puriﬁcation of ToMOC,
ToMOD, ToMOF, and ToMOH were carried out as reported
previously.15,16 NADH and N-[3-(dimethylamino)propyl]-N′-
ethylcarbodiimide (EDC) were purchased from Roche and
Sigma, respectively. ToMOH is an (αβγ)2 dimer, with
carboxylate-bridged diiron centers contained in each α subunit.
In this work, the concentration of ToMOH is represented as
that of the (αβγ)2 dimer.
Steady State Kinetics and Analysis. Reactions were
examined in 400 μL volumes of 0.1 M Tris buﬀer at pH 7.3.
Each reaction mixture contained 2 μM ToMOH (4 μM diiron
active sites), 0.5−120 μM ToMOD, 2−16 μM ToMOC, 0.1
μM ToMOF, and saturating levels of toluene (∼6 mM).17
Reactions were initiated by addition of NADH to a ﬁnal
concentration of 0.2 mM. The absorbance change at 340 nm,
corresponding to conversion of NADH to NAD+, was
monitored as a function of time. The temperature was
maintained at either 10 or 37 °C using a circulating water
bath. The reaction cuvette was held in a thermostated
compartment attached to a circulating water bath. The rate of
NADH consumption was calculated by ﬁtting the initial
absorbance change at 340 nm to a linear function. The
negative slope of this line was divided by both the extinction
coeﬃcient of NADH (6220 M−1 cm−1) and the concentration
of ToMOH diiron sites (4 μM) to yield the NADH
consumption per diiron active site. The resulting values were
plotted as a function of ToMOD concentration. Fits to the data
were examined for a standard Michaelis−Menten model, a
cooperative model, and a competitive model (eq 1).
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In all cases, ToMOD was treated as a substrate, a common
method for evaluating promoter proteins.18 The competitive
model was clearly best as indicated by the lowest adjusted R2,
the lowest error of the ﬁtted parameters, and residual values
closest to zero.
Colorimetric Reductive Titrations. Anaerobic titrations
were performed in sealed cuvettes in 50 mM potassium
phosphate and 50 mM NaCl (pH 7.0) at 25 °C. In a nitrogen-
ﬁlled chamber, solutions of 40−50 μM ToMOC and either 40
μM anthraquinone-1,5-sulfonic acid (Em° = −175 mV vs
NHE),19 100 μM 2-hydroxy-1,4-naphthoquinone (Em° = −137
mV vs NHE),20 or 17.5 μM indigo carmine (Em° = −125 mV vs
NHE)21 were prepared. Each solution was sealed in a quartz
cuvette with a screw cap equipped with a rubber septum. A
buﬀered dithionite solution was loaded into a gastight
Hamilton syringe with a repeating dispenser. The syringe and
cuvette were removed from the anaerobic chamber, and each
ToMOC/dye solution was titrated with the buﬀered solution of
dithionite. An HP diode array spectrometer was used to
monitor the UV−vis spectrum of the sample throughout the
course of the titration. The solution was allowed to reach
equilibrium, which was achieved when no further absorbance
change was observed (5−30 min). The equilibrium absorbance
spectrum for each titration point was ﬁt to a linear combination
of oxidized and reduced absorbance spectra of ToMOC and the
dye (eq 2). The reduction potential of ToMOC was
determined from a modiﬁed Nernst equation (eq 3)22
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where Edye°′ and EToMOC°′ are the midpoint potentials of the dye
and ToMOC, respectively; ndye and nToMOC are the number of
electrons that the components can acquire upon reduction; F is
Faraday’s constant; and E is the equilibrium midpoint potential
of the solution.
Stopped-Flow Kinetics and Analysis for Single-Wave-
length Measurements. Single-wavelength kinetic data were
obtained using a Hi-Tech Scientiﬁc (Salisbury, U.K.) SF-61
DX2 stopped-ﬂow spectrophotometer equipped with a photo-
multiplier tube and a tungsten lamp. To remove oxygen from
the reaction lines, the instrument was scrubbed overnight with
anaerobic buﬀer containing ∼5 mM sodium dithionite.
Immediately prior to each experiment, the stopped-ﬂow lines
were washed with dithionite-free, anaerobic buﬀer to remove
any excess dithionite. Reactions were carried out in 50 mM
potassium phosphate and 50 mM NaCl at pL 7.0. The pD was
calculated by adding 0.4 to the value reported by the pH meter.
The temperature was held constant using a circulating water
bath. Temperatures for all stopped-ﬂow reactions were 13 °C,
except where noted otherwise. Protein samples were made
anaerobic by cycling between vacuum and argon using a
Schlenk line. The anaerobic protein samples were brought into
a chamber ﬁlled with a nitrogen atmosphere for handling prior
to stopped-ﬂow analysis. In the nitrogen chamber, the two
reactants were loaded into separate Hamilton Sample-Lock
syringes equipped with a male luer adapter. The syringes were
sealed and removed from the nitrogen atmosphere for loading
onto the prewashed stopped-ﬂow. Protein concentrations listed
for stopped-ﬂow experiments are concentrations after rapid
mixing of the reaction components. Three or more individual
traces were averaged to obtain the ﬁnal traces shown here. The
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data were analyzed using OriginLabs 9.0 or 9.1. Single- and
double-exponential ﬁts were compared as models for each of
the averaged traces.
For reactions between ToMOCred and ToMOHox, ToMO-
Cred was prepared by titrating ToMOCox with a buﬀered
solution of dithionite under a nitrogen atmosphere. When the
regulatory protein was included, ToMOD was added to the
syringe containing either ToMOHox or ToMOCred. Using the
stopped-ﬂow, the absorbance change at 458 nm was monitored
for each reaction condition. This wavelength provides the
greatest diﬀerence in molar extinction coeﬃcient for the
oxidized and reduced forms of ToMOC. Single-exponential ﬁts
were adequate to ﬁt all experimental traces. In some cases,
double-exponential ﬁts resulted in lower adjusted R2 values.
However, in all cases, double-exponential ﬁts also produced
greater errors of the ﬁtted parameters. The error for double-
exponential ﬁts was greater than 10 times the output parameter.
For this reason, double-exponential ﬁts were not further
considered.
Stopped-Flow Kinetics and Analysis for Multiwave-
length Measurements. Multiwavelength kinetic data were
obtained using a Hi-Tech Scientiﬁc SF-61 DX2 stopped-ﬂow
spectrophotometer equipped with a diode array detector and a
xenon lamp. Anaerobic preparation of the stopped-ﬂow was the
same as indicated for single-wavelength measurements (above).
Reactions were carried out in 50 mM potassium phosphate and
50 mM sodium chloride at pH 7.0 and 13 °C. Under a nitrogen
atmosphere, reduced ToMOF (ToMOFred) was prepared by
adding 1.5 equiv of NADH. ToMOCox and ToMOFred were
loaded into separate Hamilton Sample-Lock syringes equipped
with a male luer lock. Absorbance changes from 380 to 750 nm
were monitored as a function of time. The reaction was very
fast (complete in 15 ms), such that only the ﬁrst three data
points displayed a change in absorbance. Because of the speed
of the reaction, the absorbance traces are shown and discussed
but were not ﬁt to a kinetic model.
Cross-Linking Experiments. A solution of 120 μM
ToMOC or ToMOF and 60 μM ToMOH was prepared in
25 mM MOPS buﬀer at pH 7.0. For reaction mixtures
containing the regulatory protein, ToMOD was added to a ﬁnal
concentration of 120 μM. The zero-atom cross-linking agent
EDC was added to the protein solution to a ﬁnal concentration
of 450 mM. The reaction mixture was kept on ice for 1 h. An
equal volume of 1 M sodium acetate and 25 mM MOPS at pH
6.8 was added after 1 h to quench the reaction. The products
were loaded onto a Sephadex S200 column (1.6 cm × 60 cm).
The protein was eluted with 25 mM MOPS (pH 7.0), 10%
glycerol (v/v), and 150 mM NaCl. Fractions of 3 mL were
collected throughout the elution. The fractions were analyzed
by UV−vis spectroscopy. The absorbance at 280 and 458 nm
was plotted as a function of elution volume.
■ RESULTS AND DISCUSSION
Eﬀect of ToMOD and ToMOC Concentration on
Steady State Activity. To assess the eﬀects of ToMOD on
catalysis, we performed steady state reactions with varying
concentrations of ToMOD. Inﬂuenced by prior reports with
three-component BMMs,4 we assessed activity at both 10 and
37 °C (Figure 1).
At substoichiometric concentrations of ToMOD, the rate of
NADH consumption increases with increasing ToMOD
concentration at both 10 and 37 °C. Under these conditions,
ToMOD acts as a promoter protein. X-ray crystallography
indicates that promotion by ToMOD arises through conforma-
tional changes exerted on ToMOH upon binding of ToMOD.
These conformational changes within the hydroxylase enable
dioxygen access to the diiron active site and subsequent oxygen
activation.13,14 With excess ToMOD, however, we observed an
inhibitory eﬀect, Ki,ToMOD.
b Importantly, ToMOD is much
more eﬀective at inhibiting the reaction at 37 °C than at 10 °C.
Similar steady state experiments were performed with varying
concentrations of ToMOC (Figure 2 and Table 1).
Upon increasing the concentration of ToMOC, there are
signiﬁcant shifts in the apparent kcat, Km,ToMOD, and Ki,ToMOD
values, as numerically shown in Table 1. The most dramatic
change is in the Ki,ToMOD, which reﬂects much weaker ToMOD
Figure 1. Steady state activity as a function of ToMOD concentration
at 10 °C (○) and 37 °C (■). Reactions of 2 μM ToMOH, 4 μM
ToMOC, 0.5−120 μM ToMOD, 0.1 μM ToMOF, and saturating
amounts of toluene (∼6 mM) were initiated by addition of 0.2 mM
NADH. The rate of NADH consumption as a function of ToMOD
concentration ﬁt well to a ToMOD inhibition model (eq 1 of the
Supporting Information). The vertical, dashed line in the ﬁgure
demarcates a 1:1 ratio of ToMOD to ToMOH diiron sites.
Figure 2. Steady state activity at various concentrations of ToMOC
graphed as a function of ToMOD concentration. At 37 °C, the rate of
NADH consumption as a function of ToMOD concentration was
determined for varying concentrations of ToMOC, 4 μM (black
squares), 8 μM (red circles), 10 μM (blue triangles), and 16 μM (pink
inverted-triangles). Each reaction mixture contained 2 μM ToMOH,
0.1 μM ToMOF, saturating toluene, and 0.2 mM NADH.
Table 1. Steady State Parameters
[ToMOC] (μM) kcat (s
−1) Km,ToMOD (μM) Ki,ToMOD (μM)
4 1.88(5) 0.57(6) 44(4)
6 2.00(5) 0.75(8) 60(5)
10 2.5(2) 0.8(1) 110(30)
16 2.34(6) 0.87(9) 330(50)
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inhibition at high concentrations of ToMOC. The dependence
of Ki,ToMOD on ToMOC concentration demonstrates that the
inhibitory function of ToMOD is linked to the action of
ToMOC.
X-ray crystallographic data indicate that binding of the
T4MO regulatory protein to its hydroxylase covers the
entrance to the aromatic substrate channel and shrinks its
diameter.11,12 Attenuation of substrate access may therefore
also contribute to inhibition at the higher ToMOD
concentrations. To assess this possibility directly, steady state
experiments with varying concentrations of ToMOD were
performed at 0.75 and 5 mM toluene (Figure 3).
The kcat,ToMOD increases from 2.1(1) s
−1 at 0.75 mM toluene
to 2.7(4) s−1 at 5 mM toluene. In contrast, Ki,ToMOD is
unaltered, yielding values of 14(2) and 17(5) μM for 0.75 and 5
mM toluene, respectively. Thus, covering of the aromatic
substrate channel by ToMOD does not aﬀect Ki,ToMOD under
the conditions presented here. Instead, this inhibition constant
depends directly on ToMOC concentration. The data provide
further support for the model involving direct competition
between ToMOC and ToMOD for binding to the hydroxylase.
This result may arise either through competition for the same
binding location or by one protein at the same site triggering
allosteric changes that alter the conformation of ToMOH and
aﬀect the binding of the other protein at a remote site.
The sites of the interaction between BMM regulatory
proteins and their respective hydroxylases are well docu-
mented.11,12,23,24 The regulatory proteins bind to the
hydroxylases in a region originally termed the “canyon” for
the ﬁrst BMM hydroxylase characterized by X-ray crystallog-
raphy, sMMOH25 from soluble methane monooxygenase
(sMMO). Subsequent X-ray crystallography demonstrated
that the canyon region occurs in all members of the BMM
family.12,23,26 The canyon is deﬁned by a signiﬁcant depression
at the surface of these hydroxylases formed between α and β
subunits across the dimer interface. The shortest distance
between the diiron active sites and the surface of the
hydroxylases, ∼12 Å, exits at one of the canyon walls, the
locale of regulatory protein binding.12,23,24 Although short
distances are not required for biochemical ET,27−29 binding of
ToMOC to ToMOH in the canyon would provide the most
eﬃcient distance for ET.30 If ToMOC were to bind in the
canyon, which we consider to be quite likely for eﬃcient ET,
ToMOD would compete with ToMOC for binding to
ToMOH.
Electron Transfer. To assess competition between
ToMOD and ToMOC for binding to ToMOH, we evaluated
intermolecular ET. Monitoring ET provides a direct assessment
of inhibition without the need to unravel the complex kinetics
of steady state turnover involving four protein components and
multiple substrates. In these investigations, we examined the
thermodynamic and kinetic parameters of ET from ToMOCred
to ToMOH by exploiting redox-dependent absorbance features
of ToMOC. Upon oxidation of ToMOCred, the absorbance at
458 nm increases 2-fold (Supporting Information), allowing for
kinetic characterization of ET to and from ToMOC as well as
facile redox determination by colorimetric methods. The
midpoint potential of ToMOC was determined by a
colorimetric reductive titration to be −130(30) mV versus
NHE (Supporting Information). This midpoint potential is
near that reported for T4moC (−173 mV vs NHE)31 and lies
between those expected for the [2Fe-2S] cluster of ToMOF
(−205 mV vs NHE at 25 °C)32 and the diiron center in
ToMOH (+48 mV vs NHE at 4 °C).5 These results indicate
that the Rieske cluster of ToMOC is thermodynamically
suitable for shuttling electrons from the redox centers of
ToMOF to the redox centers of ToMOH. ET from the reduced
ToMOF to ToMOCox is rapid (complete in <15 s) and much
faster than steady state turnover (Supporting Information).
Despite this limitation with respect to kinetic quantitation,
these results demonstrate that ET between ToMOF and
ToMOC is not rate-limiting along the ET pathway and that a
ternary complex involving ToMOF, ToMOC, and ToMOH is
not necessary for ET from ToMOF to ToMOC.
We next assessed ET to ToMOHox from ToMOCred as
monitored by stopped-ﬂow UV−vis spectroscopy. The data
were obtained using limiting concentrations of ToMOCred,
such that only a single electron would be transferred to the
hydroxylase to form one-electron reduced, mixed-valent
ToMOH (ToMOHmv). Figure 4 shows the observed rate
constants derived from single-exponential ﬁts of the absorbance
change at 458 nm. At excess ToMOH, the observed rate
constant depends linearly upon the concentration of ToMOH,
from which a second-order rate constant of 0.42(5) μM−1 s−1
could be derived (Figure 4), consistent with a bimolecular
reaction between the two proteins. The observed absorbance
change corresponded to complete oxidation of ToMOCred. At
ToMOH concentrations of ≥200 μM, the solution viscosity
began to aﬀect the instrument mixing time, and it was not
Figure 3. Turnover as a function of toluene and ToMOD
concentrations. At 37 °C, the rate of NADH consumption as a
function of ToMOD concentration was determined at 0.75 mM (■)
and 5.0 mM (○) toluene. Each reaction mixture contained 2 μM
ToMOH, 2 μM ToMOC, 0.1 μM ToMOF, toluene, and 0.2 mM
NADH.
Figure 4. ET from ToMOCred to ToMOHox as a function of ToMOH
concentration. kobs values for the reaction between 5 μM ToMOCred
and varying concentrations of ToMOHox at pH 7.0 and 13 °C. The
data ﬁt well to a linear function with a slope of 0.42(5) μM−1 s−1.
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possible to obtain meaningful results in this range. These data
do not permit the evaluation of the true ET reaction (see the
Supporting Information for more complete studies). The role
of ToMOD in this reaction is discussed in the following
section.
Eﬀect of ToMOD on ET. With the use of pre-steady state
single-mixing stopped-ﬂow experiments, we examined the eﬀect
of increasing concentrations of ToMOD, premixed with
ToMOHox, on electron transfer from ToMOCred. Under
these conditions, the observed rate constant for ET decreased
signiﬁcantly as the concentration of ToMOD increased. Figure
5 shows the average absorbance change at increasing
concentrations of ToMOD. A control experiment revealed
that preincubation of ToMOD with ToMOCred did not change
the results from those obtained in the absence of ToMOD
(Supporting Information, Figure S6). Thus, ToMOD slows the
reaction between ToMOCred and ToMOHox through its
interaction with ToMOH. An inhibitory eﬀect upon ET
could be a consequence of competitive binding, noncooperative
allosteric eﬀects including conformational changes, or an
alteration of the ToMOH redox potential in the presence of
ToMOD. The last possibility is suggested by the ﬁnding that,
for the three-component BMM soluble methane monooxyge-
nase (sMMO), addition of the regulatory protein to the
hydroxylase shifts the redox potential to a more negative value.5
Thus, alteration of the redox potential of ToMOH by ToMOD
binding would not be unprecedented. Attenuation of the redox
potential of ToMOH by ToMOD, however, would not give rise
to a Ki,ToMOD that depends on ToMOC concentration, as we
report here on the basis of steady state data. Therefore, we
propose either that ToMOD and ToMOC compete for binding
to the same location on ToMOH or that ToMOD enforces
allosteric eﬀects on ToMOH, inhibiting ET from ToMOCred to
ToMOHox throughout turnover.
Binding Interactions. To verify further that ToMOC and
ToMOH interact and that this interaction is perturbed by
ToMOD, we studied the binding of these proteins by use of the
zero-atom cross-linking agent EDC. The cross-linking reaction
was analyzed by gel chromatography to separate the products
by size without denaturation. Absorbance measurements
(Figure 6) were obtained for isolated fractions from the
column ﬂow-through. The absorbance at 458 nm was used as a
way to determine the ToMOC retention time. The elution
volumes for ToMOC and ToMOH alone are 80 and 60 mL,
respectively (Figure 6, black traces). When ToMOC and
ToMOH were incubated with EDC, the elution point of
ToMOC shifted to 55 mL, overlapping with the peak of
ToMOH alone (Figure 6, red traces). The reduction of
retention time demonstrates that cross-linking of the two
proteins increases the hydrodynamic radius of both ToMOH
and ToMOC, showing that the two proteins bind in solution.
In the presence of ToMOD, the absorption intensity at 458 nm
was much stronger in the low-molecular weight fraction than in
the high-molecular weight fraction. This result indicates that
cross-linking of ToMOC and ToMOH is less eﬃcient in the
presence of ToMOD (Figure 6, purple traces), consistent with
competition between ToMOD and ToMOC for a binding site
on ToMOH. This result cannot distinguish between allosteric
and direct competition for such a location.
ToMOF, on the other hand, did not cross-link with ToMOH
under the same reaction conditions (Supporting Information).
This result demonstrates that ToMOF would be incapable of
transferring electrons to ToMOH because the two proteins
cannot bind one another, a conclusion that is supported by the
fact that there is no steady state activity in the ToMO system in
the absence of ToMOC.9
Finally, to distinguish between direct competition and
indirect allosteric inhibition, we used a computational approach
involving an automated protein docking program.33−35 Guided
by X-ray crystal structure information,12,26,36,37 we examined
binding between T4moC and either ToMOH, T4moH, or the
T4moHD complex.c The T4MO proteins used for this docking
Figure 5. ET from ToMOCred to ToMOHox preincubated with
ToMOD. The absorbance at 458 nm was monitored for the reaction
between ToMOCred and ToMOHox preincubated with 0 μM (black),
25 μM (green), 50 μM (orange), and 125 μM (violet) ToMOD. The
absorbance change at 458 nm over time is plotted on a logarithmic
scale (top), and the observed rate constants obtained from single-
exponential ﬁts of the data are shown as a function of the ratio of
ToMOD to ToMOH diiron sites (bottom).
Figure 6. Cross-linking of ToMOC and ToMOH in the presence and
absence of ToMOD. Values of absorbance at 458 nm (top) and 280
nm (bottom) as a function of elution volume are shown. Elution of
ToMOC alone is shown with a solid black line; elution of ToMOH
alone is shown with a dotted black line. Elution of the reaction mixture
of ToMOC, ToMOH, and the cross-linking agent EDC is shown as a
red trace with red dots. Elution of the reaction mixture of ToMOC,
ToMOH, ToMOD, and the cross-linking agent EDC is shown as a
purple trace with empty squares. Absorbance measurements at 458 nm
were performed for each fraction, whereas absorbance measurements
at 280 nm were an output from the Äkta fast protein liquid
chromatography system.
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model are highly homologous with ToMO, display similar
chemistry,9,38 and have known structures from X-ray
crystallography.10−12 When T4moC was docked to either
hydroxylase alone, the preferred binding site was conclusively at
the canyon regions of the proteins (Figure 7A). This binding
mode was similar for all 10 of the lowest-energy predictions
(Chart S1 of the Supporting Information). When the T4moHD
complex was used, the best predicted T4moC binding site was
nonsensical for eﬃcient ET (Figure 7B), being far removed
from the hydroxylase diiron center, and not conserved among
the 10 lowest-energy structures provided by the docking model
(Chart S2 of the Supporting Information). Upon removal of
one of the two regulatory proteins from the hydroxylase
complex, T4moC bound to the canyon region on the side of
T4moH from which ToMOD was removed (Figure 7C). In
this case, the 10 lowest-energy structures all revealed binding of
T4moC in a canyon region of the hydroxylase (Chart S3 of the
Supporting Information). Use of the docking program
necessitated removal of the 2Fe-2S Rieske cluster (see page 1
of the Supporting Information), which limits our ability to
compute a distance for ET. The model nonetheless is
consistent with a competitive binding model supported by
ET and steady state turnover presented here and a recent X-ray
crystal structure.a
Comparison of Three- and Four-Component BMMs:
Conserved Control of Electron Transfer. The BMM
regulatory proteins have been shown (i) to couple NADH
consumption with hydrocarbon oxidation,39 (ii) to gate
hydrocarbon substrate11 and dioxygen13,14 access to the diiron
active sites, and (iii) to alter the redox potential of the catalytic
diiron active site.5,40 Competition between the reductase and
regulatory protein of the three-component BMM, sMMO, has
been described in detail.3,4,41 Recent studies of soluble butane
monooxygenase (sBMO) also reveal a dual promotion and
inhibition eﬀect of the regulatory protein on turnover.42
Because the Rieske protein of the four-component BMMs is
much smaller than the NADH oxidoreductase of three-
component BMMs, the Rieske protein might bind to the
hydroxylase in a ternary complex with the regulatory protein.
The present results, however, indicate that competitive binding
between the electron transfer partner of the hydroxylase and
the regulatory proteins is retained even in four-component
BMMs. Additional evidence for competitive binding is available
(see footnote a), which agrees with our conclusions.
Conservation of this competition in both three- and four-
component BMMs reveals that nature has preserved this
mechanism despite radically altering the ET partners,
suggesting that this feature of catalysis is indispensible.
Competitive binding between the ET and regulatory proteins
may provide a mechanism for controlling unwanted ET during
dioxygen activation protecting the oxygen-activated intermedi-
ates from unwanted reduction.3,41,43
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■ ABBREVIATIONS
ToMO, toluene/o-xylene monooxygenase; BMM, bacterial
multicomponent monooxygenase; NADH, nicotinamide ad-
enine dinucleotide; ET, electron transfer; T4MO, toluene 4-
monooxygenase; ToMOD, regulatory protein of ToMO;
ToMOC, Rieske protein of ToMO; ToMOH, hydroxylase of
ToMO; ToMOF, NADH oxidoreductase of ToMO; EDC, N-
[3-(dimethylamino)propyl]-N′-ethylcarbodiimide; ToMOCred,
one-electron-reduced Rieske protein of ToMO; ToMOHox,
oxidized hydroxylase of ToMO; ToMOFred, two- or three-
electron-reduced NADH oxidoreductase of ToMO; ToMOCox,
oxidized Rieske protein of ToMO; NHE, normal hydrogen
electrode; ToMOHmv, one-electron-reduced hydroxylase of
ToMO; ToMOHred, two-electron-reduced hydroxylase of
ToMO; sMMO, soluble methane monooxygenase.
■ ADDITIONAL NOTES
aWhile this paper was in revision, a related study of T4MO
appeared,43 to which we draw the reader’s attention. These
structural studies for T4MO are consistent with the results and
conclusions presented here.
bThe ratio of ToMOC to diiron sites in ToMOH is 1:1 for the
data in Figure 1. At this ratio, maximal NADH consumption
occurs at a 1:1 ratio of ToMOD to ToMOH diiron sites, which
was the ﬁrst indication of binding competition or allostery
during steady state catalysis.
Figure 7. Binding predictions for T4moC and ToMO and the
complex of T4moH with the regulatory protein. Shown above are
representative models for the predicted binding interactions between
T4moC and (A) ToMOH, (B) the complex of 2 equiv of the
regulatory protein and the hydroxylase of T4moH, and (C) the
complex of 1 equiv of the regulatory protein and the hydroxylase of
T4MO. The hydroxylases are represented in surface mode with the
two halves of the dimer colored yellow and gray. T4moC and the
regulatory protein are colored red and green, respectively.
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cThe Rieske, regulatory, and hydroxylase proteins of T4MO are
designated T4moC, T4moD, and T4moH, respectively. The
complex of T4moH with two regulatory proteins is termed
T4moHD.
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